Ridgetech (RDGT) AI Stock Analysis

Top Page

Ridgetech

(NASDAQ:RDGT)

Select Model

Rating:40Underperform

Price Target:$1.50▲(87.03% Upside)

Action:downgraded

Date:04/24/26

The score is weighed down primarily by weak financial performance (operating losses, recent revenue decline, and historically inconsistent cash flow) despite some 2025 stabilization from positive net income, improved cash flow, and reduced debt. Technicals further pressure the score due to a bearish trend (negative MACD and price below major moving averages), while valuation provides limited support given a negative P/E and no dividend yield data.

Positive Factors

Balance-sheet improvementMaterial debt reduction and rising equity in 2025 meaningfully improve the company's funding cushion and reduce near-term default risk. For a low-margin distributor, stronger capitalization increases resilience to demand swings and preserves strategic optionality for 2–6 months and beyond.

Negative Factors

Revenue volatility and declineAn ~18% revenue drop in 2025 and multi-year volatility signal weakening top-line stability. For a distribution business reliant on scale and tight margins, persistent revenue erosion undermines operating leverage and reduces the odds of consistent margin recovery over coming quarters.

Ridgetech (RDGT) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $721.73K
Dividend Yield: ―
Average Volume (3M): 1.51M
Price to Earnings (P/E): -0.0
Beta (1Y): 0.09
Revenue Growth: 10.16%
EPS Growth: 98.05%
Country: US
Employees: 64
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Distribution

Ridgetech Business Overview & Revenue Model

Company Description

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in...

Ridgetech Financial Statement Overview

Summary

Income statement strength is weak with volatile revenue and persistent negative EBIT margins, despite a swing to positive net income in 2025 that appears influenced by non-operating items. The balance sheet improved via meaningful debt reduction and higher equity, but leverage remains elevated for a low-margin distributor. Cash flow turned positive in 2025 (including free cash flow), yet the multi-year history of negative operating cash flow makes durability uncertain.

Income Statement

41Neutral

Balance Sheet

38Negative

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	132.16M	132.16M	119.97M	154.54M	148.81M	164.39M
Gross Profit	4.75M	4.75M	3.84M	31.11M	34.28M	36.52M
EBITDA	-1.50M	-1.50M	4.98M	1.23M	-19.96M	-579.93K
Net Income	-1.25M	-1.25M	10.19M	-4.23M	-21.14M	-3.19M
Balance Sheet
Total Assets	69.03M	69.03M	64.48M	95.06M	90.97M	106.38M
Cash, Cash Equivalents and Short-Term Investments	17.91M	17.91M	12.78M	20.15M	18.81M	18.46M
Total Debt	22.67K	22.67K	10.39M	43.22M	42.16M	48.67M
Total Liabilities	28.25M	28.25M	34.85M	80.76M	74.30M	83.65M
Stockholders Equity	40.78M	40.78M	29.64M	15.64M	18.01M	24.09M
Cash Flow
Free Cash Flow	-1.39M	-1.39M	632.50K	-4.08M	-3.60M	-5.69M
Operating Cash Flow	-1.39M	-1.39M	1.25M	-3.16M	-3.28M	-5.39M
Investing Cash Flow	-449	-449	-18.14M	-2.04M	-316.10K	-306.14K
Financing Cash Flow	-29.71K	-29.71K	1.51M	8.00M	2.37M	4.84M

Ridgetech Technical Analysis

Technical Analysis SentimentNegative

Last Price0.80

Price Trends

50DMA0.88Negative

100DMA1.06Negative

200DMA67.90Negative

Market Momentum

MACD-0.02Positive

RSI43.91Neutral

STOCH24.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RDGT, the sentiment is Negative. The current price of 0.80 is below the 20-day moving average (MA) of 0.86, below the 50-day MA of 0.88, and below the 200-day MA of 67.90, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 43.91 is Neutral, neither overbought nor oversold. The STOCH value of 24.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RDGT.

Ridgetech Risk Analysis

Ridgetech disclosed 45 risk factors in its most recent earnings report. Ridgetech reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks

1.We qualify as a "controlled company" under the Nasdaq Listing Rules. Although we do not currently intend to rely on the exemptions available to controlled companies (relying instead on certain exemptions available to us as a foreign private issuer, as described under Item 16G. Corporate Governance below), we may elect to rely on some or all of the exemptions available to controlled companies in the future, in which case our shareholders may not have the same governance protections afforded to shareholders of companies that are subject to all applicable Nasdaq corporate governance requirements.Q1, 2026

2.We have identified material weaknesses in our internal control over financial reporting, and our disclosure controls and procedures were ineffective as of March 31, 2026. If we fail to remediate these weaknesses, our ability to report our financial results accurately and timely could be adversely affected.Q1, 2026

Ridgetech Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

RDGT against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GEG	46Neutral	$66.52M	-1.86	-67.45%	―	70.24%	-341.49%
RDGT	40Underperform	$2.91M	-0.00	-3.54%	―	10.16%	98.05%

* Healthcare Sector Average

Performance Comparison

RDGT and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	RDGT	Ridgetech, Inc.	0.80	-252.70	-99.68%
	GEG	Great Elm Group, Inc.	2.15	-0.34	-13.65%

Ridgetech Corporate Events

Ridgetech Switches Sales Agent, Extends $184.7 Million At-The-Market Share Program

Jul 28, 2026

On July 28, 2026, Ridgetech Inc. signed a new sales agreement with Pacific Century Securities LLC to continue its at-the-market equity offering program for ordinary shares with a potential aggregate value of up to $184.7 million. The arrangement foll...

Ridgetech Tightens Governance Control With Super-Voting Preferred Share Issuance and Nasdaq Exemptions

Jul 21, 2026

On July 21, 2026, Ridgetech disclosed that it is availing itself of Nasdaq’s home-country practice exemptions, allowing the company to follow Cayman Islands corporate governance rules instead of certain Nasdaq Listing Rules, including requireme...

Ridgetech Halts $200 Million ATM Share Offering After Terminating AC Sunshine Deal

Jul 20, 2026

On July 11, 2026, Ridgetech, Inc. terminated its Sales Agreement with AC Sunshine Securities LLC, immediately halting its at-the-market equity offering of up to $200 million in ordinary shares. The company suspended further sales under this program a...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Apr 23, 2026

Ridgetech AI Stock Analysis